Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AKAP1-DT, also known as AKAP1 divergent transcript, is not a well-established canonical protein or therapeutic target. Instead, it refers to a non-coding divergent transcript located at the AKAP1 gene locus. Its function, classification, and disease relevance are currently unclear. It is identified in gene databases as a non-coding RNA. In contrast, AKAP1 (A-kinase anchoring protein 1) is a well-characterized scaffold protein involved in recruiting PKA and other signaling proteins to the outer mitochondrial membrane, influencing mitochondrial dynamics, neuronal development, and cell survival.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AKAP1 divergent transcript (AKAP1-DT).